Scientific Publications

The landmark research of BostonGene underscores the importance of combining innovative multi-platform analytics with cutting-edge software to improve patient outcomes. Explore our scientific publications to learn more.

  • 2022

Multiregional single-cell proteogenomic analysis of ccRCC reveals cytokine drivers of intratumor spatial heterogeneity

More
  • 2022

Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes

More
  • 2022

B cell content in the tumor microenvironment is associated with improved survival in stage II lung adenocarcinoma

More
  • 2022

Tumor microenvironment heterogeneity identifies potential biomarkers of response in ER-positive breast cancers treated with palbociclib

More
  • 2022

Viral transcript and tumor immune microenvironment-based transcriptomic profiling of HPV-associated head and neck cancer identifies subtypes associated with prognosis

More
  • 2022

Deep immune profiling by mass cytometry revealed an association between the state of immune system before treatment and response to checkpoint inhibitor therapy in clear cell renal cell carcinoma

More
  • 2022

Combinatory technologies for single sample gene expression projection onto a cohort sequenced with a different technology for personalized clinical decision-making

More
  • 2022

Molecular-based tumor grade predictor for breast cancer, clear cell renal cell carcinoma, and lung adenocarcinoma

More
  • 2022

Follicular lymphoma microenvironment characteristics associated with tumor cell mutations and MHC class II expression

More
  • 2022

A digital imaging analysis (DIA) platform for identifying tertiary lymphoid structures (TLS) in lung adenocarcinoma (LUAD).

More